B
Novo Nordisk A/S NONOF
$96.13 -$1.25-1.29%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 8.58B 7.93B 7.69B 6.61B 6.17B
Total Other Revenue -- -- -- -- --
Total Revenue 8.58B 7.93B 7.69B 6.61B 6.17B
Cost of Revenue 1.42B 1.15B 1.18B 1.13B 975.13M
Gross Profit 7.16B 6.79B 6.51B 5.47B 5.20B
SG&A Expenses 2.06B 2.25B 1.94B 2.07B 1.71B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -14.31M 2.19M -4.75M -66.48M -8.13M
Total Operating Expenses 4.65B 4.44B 4.09B 4.15B 3.44B
Operating Income 3.93B 3.49B 3.60B 2.46B 2.73B
Income Before Tax 4.10B 3.54B 3.56B 2.24B 2.44B
Income Tax Expenses 815.64M 705.13M 709.33M 374.17M 491.22M
Earnings from Continuing Operations 3.28B 2.84B 2.85B 1.87B 1.95B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 3.28B 2.84B 2.85B 1.87B 1.95B
EBIT 3.93B 3.49B 3.60B 2.46B 2.73B
EBITDA 4.30B 3.81B 3.85B 2.64B 3.01B
EPS Basic 0.73 0.63 0.63 0.41 0.43
Normalized Basic EPS 0.57 0.49 0.50 0.34 0.34
EPS Diluted 0.73 0.63 0.63 0.41 0.43
Normalized Diluted EPS 0.57 0.49 0.49 0.34 0.34
Average Basic Shares Outstanding 4.48B 4.49B 4.50B 4.51B 4.52B
Average Diluted Shares Outstanding 4.49B 4.50B 4.51B 4.52B 4.54B
Dividend Per Share 0.00 0.44 -- 0.56 0.00
Payout Ratio 59.75% 0.00% 92.55% 0.00% 66.73%
Weiss Ratings